May 23, 2023, Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) trading session started at the price of $26.95, that was 1.22% jump from the session before. During the day, the shares moved up to $27.98 and dropped to $26.70 before settling in for the closing price of $27.07. A 52-week range for AMLX has been $7.64 – $41.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -117.80%. With a float of $49.98 million, this company’s outstanding shares have now reached $66.72 million.
Considering the fact that the conglomerate employs 262 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is +84.35, operating margin of -905.72, and the pretax margin is -888.89.
Amylyx Pharmaceuticals Inc. (AMLX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amylyx Pharmaceuticals Inc. stocks. The insider ownership of Amylyx Pharmaceuticals Inc. is 23.46%, while institutional ownership is 65.70%. The most recent insider transaction that took place on May 16, was worth 875,451. In this transaction Chief Financial Officer of this company sold 32,500 shares at a rate of $26.94, taking the stock ownership to the 55,676 shares. Before that another transaction happened on May 15, when Company’s Chief Medical Officer sold 11,965 for $29.03, making the entire transaction worth $347,358. This insider now owns 208,417 shares in total.
Amylyx Pharmaceuticals Inc. (AMLX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted $0.02 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.24) by $0.26. This company achieved a net margin of -892.38 while generating a return on equity of -92.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -117.80% per share during the next fiscal year.
Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) Trading Performance Indicators
You can see what Amylyx Pharmaceuticals Inc. (AMLX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 3.45 in one year’s time.
Technical Analysis of Amylyx Pharmaceuticals Inc. (AMLX)
Compared to the last year’s volume of 0.92 million, its volume of 0.9 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 17.23%. Additionally, its Average True Range was 1.44.
During the past 100 days, Amylyx Pharmaceuticals Inc.’s (AMLX) raw stochastic average was set at 6.80%, which indicates a significant decrease from 25.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.02% in the past 14 days, which was lower than the 51.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.33, while its 200-day Moving Average is $32.30. Nevertheless, the first resistance level for the watch stands at $28.02 in the near term. At $28.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $29.30. If the price goes on to break the first support level at $26.74, it is likely to go to the next support level at $26.08. Now, if the price goes above the second support level, the third support stands at $25.46.
Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) Key Stats
There are 67,176K outstanding shares of the company, which has a market capitalization of 1.85 billion. As of now, sales total 22,230 K while income totals -198,380 K. Its latest quarter income was 71,430 K while its last quarter net income were 1,570 K.
